Can You Die From Stage 4 Endometriosis?

Stage 4 endometriosis is not classified as a terminal illness, and the disease itself does not directly kill in the way a cancer might. But the complications it produces can be life-threatening, and several large studies now link confirmed endometriosis to a modestly higher risk of premature death from specific causes. The honest answer is more unsettling than a flat “no”: death from endometriosis is rare but documented, and the pathways to serious harm are more varied than most people realize.

What Large Mortality Studies Actually Show

Researchers have tried for years to pin down whether endometriosis shortens life, and the results are genuinely contradictory. A large Danish cohort study covering roughly 2.5 million person-years of observation found that women with surgically confirmed endometriosis had lower all-cause mortality than the general population, with about four fewer deaths per 1,000 women over a decade. Cardiovascular and cancer death rates were also lower in that group.¹ That finding has been interpreted partly as a “surveillance bias” effect: women with endometriosis see doctors more often, so other diseases get caught earlier.

A prospective study from the Nurses’ Health Study II, published in the BMJ, reached a starkly different conclusion. After adjusting for behavioral factors, women with laparoscopically confirmed endometriosis had roughly a 31% higher risk of premature death. The elevated risk was driven by cancer mortality, respiratory disease mortality, and especially gynecological malignancies, where the risk was nearly three times higher.² A separate analysis using U.S. national survey data found that when endometriosis was diagnosed at age 30 or younger, both all-cause and cardiovascular mortality risks were significantly higher, but the association faded for women diagnosed later.³

These studies are not easily reconciled. Differences in how endometriosis was confirmed, which populations were studied, and which confounders were adjusted for all play a role. The takeaway is that endometriosis is not a benign condition in the way it was historically treated, and the mortality signal, while still debated, has become harder to dismiss.

Acute Emergencies That Can Turn Fatal

The most immediately dangerous complications of advanced endometriosis are the ones that mimic surgical emergencies. An endometrioma, the blood-filled ovarian cyst that characterizes stage 4 disease, can rupture and spill its contents into the abdominal cavity. This causes hemoperitoneum, meaning free blood pooling inside the abdomen. In one documented case, a 48-year-old woman presented in hypovolemic shock during menstruation, and surgeons evacuated nearly 1,900 mL of blood from her pelvis. The bleeding turned out to come from endometriotic implants on the peritoneum rather than from a ruptured cyst itself.⁴ Other cases have documented ruptured endometriomas presenting with signs identical to a ruptured ectopic pregnancy, requiring emergency surgery to stop the bleeding.⁵

Deep infiltrating endometriosis can also invade the bowel wall to the point where it perforates. A case of ileocecal perforation directly caused by endometriosis has been reported, and while the literature describes only a small number of such events overall, bowel perforation from any cause carries a high risk of peritonitis and sepsis if not treated quickly.⁶ In one pregnancy-related case, decidualized endometriosis caused spontaneous rectal perforation, leading to severe fecal contamination of the abdominal cavity.⁷ Fewer than two dozen cases of bowel perforation from endometriosis had been reported at that time, but each one underscores that this disease can produce a genuine surgical emergency.

In rarer scenarios, endometriosis can erode into major blood vessels. Two documented cases involved endometriosis infiltrating the uterine artery and causing sudden intra-abdominal hemorrhage.⁸ These events, while extremely uncommon, highlight the fact that advanced disease can reach vital structures.

Silent Organ Damage

Not all of the danger is dramatic. Ureteral endometriosis is one of the more insidious forms of the disease. Endometrial implants can grow around or into the ureters, the tubes connecting the kidneys to the bladder, and gradually obstruct urine flow. Because this process produces few or no symptoms in its early stages, by the time it is recognized the kidney on the affected side may already be permanently damaged. Three documented cases demonstrated complete loss of kidney function on one side from this mechanism.⁹ A separate case series confirmed that ureteral endometriosis can silently lead to hydronephrosis and ultimately renal failure.¹⁰

Diagnosis of ureteral involvement is often delayed by nearly two years on average after the first signs of mild obstruction appear, largely because the symptoms are vague and nonspecific.¹¹ Losing one kidney is survivable, but it reduces your reserve. And the broader point matters: an observational study found that women with endometriosis in the vagina, bowel, or bladder experienced significantly longer diagnostic delays, and the authors emphasized the risk of irreversible organ damage when treatment comes too late.¹²

Thoracic Endometriosis and Collapsed Lungs

Endometriosis can establish itself in the chest cavity, a condition known as thoracic endometriosis syndrome. The most common presentation is catamenial pneumothorax, a collapsed lung that recurs in sync with menstruation. A case report noted that diagnosis is easily missed or delayed, causing repeated hospitalizations and what the authors described as life-threatening complications.¹³ A tension pneumothorax, where the collapsed lung allows air to build up and compress the heart and remaining lung, can kill within minutes if not treated. Catamenial hemothorax, where blood accumulates in the chest cavity during menstruation, is another presentation that can require emergency intervention. These are rare manifestations, but they represent a pathway through which endometriosis can directly threaten life.

Blood Clots and Pulmonary Embolism

A large Danish nationwide study found that women with endometriosis had about a 50% higher risk of venous thromboembolism compared to controls, even after adjusting for hormonal contraceptive use and other relevant conditions. The elevated risk applied to both deep vein thrombosis and pulmonary embolism specifically.¹⁴ Pulmonary embolism, where a blood clot lodges in the arteries of the lung, is a well-recognized cause of sudden death. The chronic inflammatory state associated with endometriosis, combined with the hormonal treatments often used to manage it, likely contributes to this elevated clotting risk.

The risk may not be evenly distributed across age groups. A population-based study found that the association between endometriosis and venous thromboembolism was strongest in younger women aged 18 to 24 and actually decreased among women 35 and older.¹⁵ In at least one reported case, retroperitoneal endometriosis directly compressed the iliac vein and triggered deep vein thrombosis, with the patient experiencing cyclical leg swelling that worsened with each menstrual period before culminating in a clot.¹⁶

When Surgery Itself Becomes Dangerous

Stage 4 endometriosis often requires complex surgery, particularly when disease involves the bowel, bladder, or ureters. These operations carry real risks. A U.S. study of colorectal resections for endometriosis found that major postoperative complications occurred in about 14% of women. Blood transfusion was the most common major complication, followed by unplanned reoperation and surgical site infection. Sepsis occurred in roughly 15% of those who had complications. Notably, mortality in that study was zero.¹⁷ A separate analysis of 364 consecutive bowel surgeries for endometriosis reported that about 12% of patients experienced complications requiring further intervention, including rectovaginal fistula in nearly 4% and pelvic abscess in about 7%.¹⁸

In very rare cases, surgical complications can be fatal. One case report described lethal hemorrhage from erosion of the external iliac artery more than three weeks after laparoscopic surgery for deep infiltrating endometriosis. A ureterovaginal fistula had developed postoperatively, and local inflammation led to perforation and ultimately fatal bleeding from the adjacent artery.¹⁹ A large single-center series of 900 bowel resections for endometriosis concluded that complication rates were acceptable and that symptoms improved over time for most patients, but acknowledged that some complications, particularly neurological damage affecting bladder function, can persist.²⁰

Infections and Abscess Formation

Endometriomas can become infected, forming tubo-ovarian abscesses. This is rare, with one estimate putting the incidence at around 2.3% in patients who have endometriomas.²¹ Infection can follow invasive procedures or arise from bacterial spread through the bloodstream or lymphatic system, and in some cases it develops spontaneously with no identifiable trigger.²² If an infected endometrioma ruptures, it can cause diffuse peritonitis, a condition that requires emergency surgery and carries significant mortality. Bacterial vaginosis has also been implicated as a potential source: in one case, a woman with advanced endometriosis developed a superinfected endometrioma after the infection ascended from the lower genital tract, and she failed to respond to antibiotic therapy alone.²³

Mental Health, Suicide, and Opioid Risks

The ways endometriosis can contribute to death extend beyond the physical complications of the disease itself. A nationwide cohort study in Taiwan found that women with endometriosis had a roughly 45% higher risk of suicide after adjusting for other conditions, along with significantly elevated rates of depression, anxiety, and sleep disorders.²⁴ In clinical samples, about 20% of women with endometriosis reported suicidal ideation, a rate significantly higher than in comparison groups. The women most at risk tended to have worse physical health, more surgeries, and higher levels of self-blame.²⁵ A systematic review and meta-analysis confirmed these patterns, noting that the suicide and all-cause mortality findings underscore the need for treating endometriosis as more than a gynecological problem.²⁶

Pain management itself introduces another pathway to harm. Women with endometriosis are nearly four times more likely to become chronic opioid users and more than four times more likely to experience an opioid overdose compared to women without the disease.²⁷ The risk is compounded by prescribing patterns: women with endometriosis are more likely to fill prescriptions at higher opioid doses and are nearly twice as likely to have overlapping prescriptions for opioids and benzodiazepines, a combination known to dramatically increase the risk of fatal respiratory depression.²⁸ Opioid overdose deaths are a leading cause of death among younger women in the United States, and the elevated exposure in the endometriosis population is not a footnote.

The Cancer Connection

Endometriosis has a well-documented association with certain ovarian cancers, particularly clear cell and endometrioid subtypes. A review of the clinical, pathological, and molecular evidence found that endometriosis-associated ovarian cancers tend to be diagnosed at an earlier stage and lower grade than non-endometriosis-associated ovarian cancers, which generally translates to a better prognosis.²⁹ The absolute risk of ovarian cancer in any individual woman with endometriosis remains low, but the BMJ cohort study found that mortality from gynecological malignancies was nearly three times higher in women with laparoscopically confirmed endometriosis than in those without.² This is one of the areas where the mortality data has become most concerning in recent years, because it suggests that even though each individual’s ovarian cancer risk is small, the collective burden on the endometriosis population is measurable.

Pregnancy Complications in Stage 4 Disease

Women with stage 4 endometriosis who do become pregnant face higher rates of several obstetric complications. A study comparing pregnancy outcomes across endometriosis stages found that all cases of preeclampsia occurred in stage 4 patients, and about two-thirds of preterm labor cases were in the same group. Rates of antepartum bleeding, gestational diabetes, placental complications, and NICU admissions were all higher in stage 4, though some of those differences did not reach statistical significance given the sample sizes.³⁰ Preeclampsia and placental complications can be life-threatening to the mother, and the bowel perforation case described earlier occurred specifically during pregnancy, illustrating how the physiological changes of pregnancy can worsen existing disease.

Autoimmune Disease Burden

Endometriosis is also linked to a higher prevalence of autoimmune conditions, which adds another layer of long-term health risk. A systematic review and meta-analysis found that women with endometriosis had roughly 36% greater odds of systemic lupus erythematosus, 76% greater odds of Sjögren syndrome, 50% greater odds of rheumatoid arthritis, and four times greater odds of chronic liver disease compared to women without endometriosis.³¹ None of these conditions are typically fatal on their own in the short term, but they contribute to a cumulative inflammatory and disease burden that can affect quality of life and long-term health outcomes. Lupus in particular carries its own mortality risk through kidney involvement and cardiovascular complications.

Hormonal Treatment Side Effects

One of the mainstay treatments for severe endometriosis, GnRH agonist therapy, comes with its own safety profile that deserves mention. These drugs suppress estrogen to levels similar to menopause, and their use is typically limited to six months because of bone density loss and vasomotor symptoms like hot flashes.³² In a study of adolescents who used GnRH agonists with add-back hormone therapy, 80% reported side effects lasting more than six months after stopping, and nearly half considered some effects irreversible, including memory loss and insomnia.³³ Longer-term use has been associated with bone mineral density reductions that do not fully recover even six years after treatment ends.³⁴ While these effects are not acutely life-threatening, accelerated bone loss increases fracture risk later in life, and fractures in older adults carry their own mortality consequences.